Role of Prolyl Hydroxylation in Oncogenically Stabilized Hypoxia-inducible Factor-1α
Open accessThe DOI matches its Crossref record; 24 of the 25 references it cites were found in a registry or an index.
Abstract
Stabilization of the hypoxia-inducible factor-1 (HIF-1) protein is essential for its role as a regulator of gene expression under low oxygen conditions. Here, employing a novel hydroxylation-specific antibody, we directly show that proline 564 of HIF-1alpha and proline 531 of HIF-2alpha are hydroxylated under normoxia. Importantly, HIF-1alpha Pro-564 and HIF-2alpha Pro-531 hydroxylation is diminished with the treatment of hypoxia, cobalt chloride, desferrioxamine, or dimethyloxalyglycine, regardless of the E3 ubiquitin ligase activity of the von Hippel-Lindau (VHL) tumor suppressor gene. Furthermore, in VHL-deficient cells, HIF-1alpha Pro-564 and HIF-2alpha Pro-531 had detectable amounts of hydroxylation following transition to hypoxia, indicating that the post-translational modification is not reversible. The introduction of v-Src or RasV12 oncogenes resulted in the stabilization of normoxic HIF-1alpha and the loss of hydroxylated Pro-564, demonstrating that oncogene-induced stabilization of HIF-1alpha is signaled through the inhibition of prolyl hydroxylation. Conversely, a constitutively active Akt oncogene stabilized HIF-1alpha under normoxia independently of prolyl hydroxylation, suggesting an alternative mechanism for HIF-1alpha stabilization. Thus, these results indicate distinct pathways for HIF-1alpha stabilization by different oncogenes. More importantly, these findings link oncogenesis with normoxic HIF-1alpha expression through prolyl hydroxylation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Tissue culture cells, particularly cells with activated oncogenic pathways, can accumulate HIFα in a nonhydroxylated form under well-oxygenated conditions (Chan et al., 2002).”
From Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. (2008) · cites this paper as Chan et al., 2002
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Semenza, G. L., & Wang, G. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.12.5447 · Cited by 2,617
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., & Giaccia, A. J. (1996) · Nature · doi:10.1038/379088a0 · Cited by 2,300
Self-citationOhh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T.-Y., Huang, L. E., Pavletich, N., Chau, V., & Kaelin, W. G. (2000) · Nature Cell Biology · doi:10.1038/35017054 · Cited by 1,577
Asparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch
Lando, D., Peet, D. J., Whelan, D. A., Gorman, J. J., & Whitelaw, M. L. (2002) · Science · doi:10.1126/science.1068592 · Cited by 1,558
Oxygen sensing and molecular adaptation to hypoxia
Bunn, H. F., & Poyton, R. O. (1996) · Physiological Reviews · doi:10.1152/physrev.1996.76.3.839 · Cited by 1,172
Research works printed but not linked: 3
- Semenza, G. L., and Wang, G. L. (1992) Mol. Cell. Biol. 12, 5447-5454
- Jiang, B. H., Agani, F., Passaniti, A., and Semenza, G. L. (1997) Cancer Res. 57, 5328 -5335
- Ryan, H. E., Poloni, M., McNulty, W., Elson, D., Gassmann, M., Arbeit, J. M., and Johnson, R. S. (2000) Cancer Res. 60, 4010 -4015
Cited by
Items 101–200 of 299
Cellular reaction to hypoxia: sensing and responding to an adverse environment
Papandreou, I., Powell, A. A., Lim, A. L., & Denko, N. C. (2004) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2004.06.054 · Cited by 90
Self-citationGrowth Factor-Mediated Induction of HDM2 Positively Regulates Hypoxia-Inducible Factor 1α Expression
Bárdos, J. I., Chau, N.-M., & Ashcroft, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.7.2905-2914.2004 · Cited by 87
“HIF-1 protein levels have been shown to be upregulated by activated Akt/PKB (39) via a VHL-independent mechanism (7, 9 ). Growth factors, such as IGF-1, induce HIF-1 protein expression by enhancing protein synthesis (13, 14).”
BackgroundJiang, Y., Xue, Z.-H., Shen, W.-Z., Du, K.-M., Yan, H.-M., Yu, Y., Peng, Z.-G., Song, M.-G., Tong, J.-H., Chen, Z., et al. (2005) · Leukemia · doi:10.1038/sj.leu.2403734 · Cited by 87
Hypoxia-inducible factor in cancer angiogenesis: Structure, regulation and clinical perspectives
Otrock, Z. K., Hatoum, H. A., Awada, A. H., Ishak, R. S., & Shamseddine, A. I. (2009) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2009.01.001 · Cited by 87
“[62] Chan DA, Sutphin PD, Denko NC, Giaccia AJ.”
BackgroundMackay, C., & Knock, G. A. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2014.285304 · Cited by 86
“In normoxia, HIF levels are kept low by prolyl hydroxylation and subsequent proteolysis; however, in response to chronic hypoxia, ROS-induced SrcFKs phosphorylate and inhibit prolyl hydroxylase (PLH) and/or von Hippel-Lindau tumour suppressor protein (VHL), thus increasing the availability of HIF (Chan et al. 2002; Sa…”
BackgroundInfluentialLund, E. L., Høg, A. M., Olsen, M. W. B., Hansen, L. T., Engelholm, S. A., & Kristjansen, P. E. G. (2004) · International Journal of Cancer · doi:10.1002/ijc.11662 · Cited by 84
Fetal Growth Plate: A Developmental Model of Cellular Adaptation to Hypoxia
Provot, S., & Schipani, E. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1402.076 · Cited by 83
Najafi, R., & Sharifi, A. M. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.782390 · Cited by 80
“Accordingly, stabilization of HIF-1a is essential for the proper functioning of this transcription factor as a regulator of gene expression under hypoxia [6,23].”
BackgroundHypoxia upregulates osteopontin expression in NIH-3T3 cells via a Ras-activated enhancer
Zhu, Y., Denhardt, D. T., Cao, H., Sutphin, P. D., Koong, A. C., Giaccia, A. J., & Le, Q. (2005) · Oncogene · doi:10.1038/sj.onc.1208800 · Cited by 79
“Luciferase activity was determined by using luciferase assay reagent (Promega, Madison, WI, USA) in a Monolight 2010 Luminometer (Analytical Luminescence Laboratory, Sparks, MD, USA), as previously described (Chan et al., 2002).”
MethodSelf-citationHIF2AMutations in Paraganglioma with Polycythemia
Favier, J., Buffet, A., & Gimenez‐Roqueplo, A. (2012) · New England Journal of Medicine · doi:10.1056/nejmc1211953 · Cited by 78
Fransén, K., Fenech, M. P., Fredrikson, M. G., Dabrosin, C., & Söderkvist, P. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20209 · Cited by 77
“hydroxylation-independent pathway compared to the common mechanism via von Hippel–Lindau (VHL) and ubiquitin-proteasome degradation [25].”
MethodHulley, P. A., Bishop, T., Vernet, A., Schneider, J. E., Edwards, J., Athanasou, N. A., & Knowles, H. J. (2017) · The Journal of Pathology · doi:10.1002/path.4906 · Cited by 77
“However, HIF-α accumulates under conditions associated with either reduced PHD enzyme activity (for example, hypoxia [4,5] or oncogenic mutation [6]) or enhanced translation of HIF-α such that it exceeds the substrate capacity of the PHD enzymes (for example, insulin [7] or hepatocyte growth factor (HGF) [8] exposure).”
BackgroundNewcomb, E. W., Ali, M. A., Schnee, T., Lan, L., Lukyanov, Y., Fowkes, M., Miller, D. C., & Zagzag, D. (2005) · Neuro-Oncology · doi:10.1215/s1152851704000997 · Cited by 72
“HIF- 1 expression can be stabilized in cells under normoxic conditions by using hypoxia mimetics such as CoCl2 ( Chan et al., 2002; Zagzag et al., 2000).”
Leu‐574 of human HIF‐1α is a molecular determinant of prolyl hydroxylation
Kageyama, Y., Koshiji, M., To, K. K. W., Tian, Y., Ratcliffe, P. J., & Huang, L. E. (2004) · The FASEB Journal · doi:10.1096/fj.03-1233fje · Cited by 68
“We investigated the status of Pro-564 hydroxylation with the use of an antibody specifically against Hyp-564, an approach similar to a previous report (37).”
ResultRedox Circuitries Driving Src Regulation
Giannoni, E., & Chiarugi, P. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5525 · Cited by 69
“Alter-natively, Chan et al. suggested that Src blocks degradation of HIF-1 a by inhibition of its prolyl hydroxylation (19).”
A HIF-Regulated VHL-PTP1B-Src Signaling Axis Identifies a Therapeutic Target in Renal Cell Carcinoma
Suwaki, N., Vanhecke, E., Atkins, K. M., Graf, M., Swabey, K., Huang, P., Schraml, P., Moch, H., Cassidy, A. M., Brewer, D., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002004 · Cited by 66
Hypoxia and HIF‐1α in Chondrogenesis
SCHIPANI, E. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1346.009 · Cited by 62
Distinct aerobic and hypoxic mechanisms of HIF-α regulation by CSN5
Bemis, L., Chan, D. A., Finkielstein, C. V., Qi, L., Sutphin, P. D., Chen, X., Stenmark, K., Giaccia, A. J., & Zundel, W. (2004) · Genes & Development · doi:10.1101/gad.1180104 · Cited by 71
“Transfections and retroviral infections were carried out as previously described (Chan et al. 2002).”
MethodSelf-citationPark, S. I., Shah, A. N., Zhang, J., & Gallick, G. E. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.9.1207 · Cited by 70
“In addition, Chan and colleagues first demonstrated a distinct mechanism of HIF-1α stabilization by Src [29] .”
BackgroundAprelikova, O. N., Pandolfi, S., Tackett, S. A., Ferreira, M., Salnikow, K., Ward, Y., Risinger, J. I., Barrett, J. C., & Niederhuber, J. E. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-0811 · Cited by 68
“cellular oncogenes, v-Src and activated Ras, are capable of inducing HIF by blocking PHD (23).”
Tan, Z., Niu, B., Tsang, K. Y., Melhado, I. G., Ohba, S., He, X., Huang, Y., Wang, C., McMahon, A. P., Jauch, R., et al. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007346 · Cited by 67
Self-citationNewcomb, E. W., Lukyanov, Y., Schnee, T., Ali, M., Li, L., & Zagzag, D. (2006) · International Journal of Oncology · doi:10.3892/ijo.28.5.1121 · Cited by 67
Induction of Hypoxia-inducible Factor 1 Activity by Muscarinic Acetylcholine Receptor Signaling
Hirota, K., Fukuda, R., Takabuchi, S., Kizaka-Kondoh, S., Adachi, T., Fukuda, K., & Semenza, G. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405164200 · Cited by 60
RetractedWang, C., Yuan, J., Wang, C., Yang, N., Chen, J., Liu, D., Song, J., Feng, L., Tan, X., & Jia, X. (2016) · Integrative Cancer Therapies · doi:10.1177/1534735416659358 · Cited by 64
D’Angelo, G., Duplan, E., Vigne, P., & Frelin, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211293200 · Cited by 63
Zheng, X., Ruas, J. L., Cao, R., Salomons, F. A., Cao, Y., Poellinger, L., & Pereira, T. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02236-05 · Cited by 56
“HIF-1 can be observed in hypoxic cells (8), which leads us to”
BackgroundHIF-1’s Relationship to Oxygen: Simple yet Sophisticated
Maxwell, P. (2004) · Cell Cycle · doi:10.4161/cc.3.2.616 · Cited by 53
Dioxygenases as O2-dependent regulators of the hypoxic response pathway
Dann, C. E., & Bruick, R. K. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.140 · Cited by 62
Astuti, D., Ricketts, C. J., Chowdhury, R., McDonough, M. A., Gentle, D., Kirby, G., Schlisio, S., Kenchappa, R. S., Carter, B. D., Kaelin, W. G., et al. (2010) · Endocrine Related Cancer · doi:10.1677/erc-10-0113 · Cited by 55
Novel Function of Orphan Nuclear Receptor Nur77 in Stabilizing Hypoxia-inducible Factor-1α
Yoo, Y.-G., Yeo, M. G., Kim, D. K., Park, H., & Lee, M.-O. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408554200 · Cited by 58
The role of connexin43–Src interaction in astrocytomas: A molecular puzzle
Tabernero, A., Gangoso, E., Jaraíz-Rodríguez, M., & Medina, J. M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.02.029 · Cited by 59
Contribution of hypoxia inducible factor-1 during viral infections
Reyes, A., Corrales, N., Gálvez, N. M. S., Bueno, S. M., Kalergis, A. M., & González, P. A. (2020) · Virulence · doi:10.1080/21505594.2020.1836904 · Cited by 59
Birle, D. C., & Hedley, D. W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2722 · Cited by 58
“Hydroxylation at Pro(402)/Pro(564) seems to be an irreversible process (39, 40) and increases pVHL affinity for HIF-1a by several orders of magnitude (17, 18, 45).”
Von Hippel-Lindau Disease: A Genetic and Clinical Review
Haddad, N. M. N., Cavallerano, J. D., & Silva, P. S. (2013) · Seminars in Ophthalmology · doi:10.3109/08820538.2013.825281 · Cited by 56
“Mutations were found to affect the HIFindependent pathways(27) or other oncogenes or tumor suppressor genes.(28) Mack et al.”
BackgroundProline-Hydroxylated Hypoxia-Inducible Factor 1α (HIF-1α) Upregulation in Human Tumours
Snell, C. E., Turley, H., McIntyre, A., Li, D., Masiero, M., Schofield, C. J., Gatter, K. C., Harris, A. L., & Pezzella, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088955 · Cited by 59
Kim, H., Chung, H., Yoo, Y., Kim, I. H., Lee, J., Lee, M., & Kong, G. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0218 · Cited by 55
Heikkilä, A., Tuomisto, T. T., Häkkinen, S.-K., Keski‐Nisula, L., Heinonen, S. T., & Ylä‐Herttuala, S. (2005) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1080/j.0001-6349.2005.00814.x · Cited by 55
Valle‐Casuso, J. C., González-Sánchez, A., Medina, J. M., & Tabernero, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032448 · Cited by 53
“Since c-Src has been shown to up-regulate HIF-1a [31,32,33], we investigated whether c-Src mediates the effect of ET-1 and Cx43 on glucose uptake.”
BackgroundInfluentialCritical role of TRPC6 in maintaining the stability of HIF-1α in glioma cells under hypoxia
Li, S., Wang, J., Yi, W., Liu, Y., Ding, X., Dong, B., Xu, Y., & Wang, Y. (2015) · Journal of Cell Science · doi:10.1242/jcs.173161 · Cited by 53
“Similar findings have also been reported previously (Chan et al., 2002).”
ResultChoi, K.-O., Lee, T., Lee, N., Kim, J., Yang, E. G., Yoon, J. M., Kim, J. H., Lee, T. G., & Park, H. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.015271 · Cited by 53
“In addition to hypoxia, Co(II) ion, and iron chelators, which inhibit the catalytic activity of PHDs, as well as other agents such as growth factors and the oncogenes Ras, active Src, and Akt have been reported to activate HIF-1 under normoxia (Zundel et al., 2000; Chan et al., 2002; Karni et al., 2002).”
BackgroundSM-20, EGL-9, and the EGLN Family of Hypoxia-inducible Factor Prolyl Hydroxylases
Freeman, R. S., Hasbani, D. M., Lipscomb, E. A., Straub, J. A., & Xie, L. (2003) · Molecules and Cells · doi:10.1016/s1016-8478(23)13758-7 · Cited by 52
Radiation sensitization with redox modulators: A promising approach
Rosenberg, A. R., & Knox, S. J. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.10.013 · Cited by 52
Stem Cell Differentiation and Lumen Formation in Colorectal Cancer Cell Lines and Primary Tumors
Ashley, N., Yeung, T. M., & Bodmer, W. F. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0454 · Cited by 51
Topalovski, M., Hagopian, M., Wang, M., & Brekken, R. A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.730945 · Cited by 51
Hipoxia tumoral. Papel del factor inducible por hipoxia
Fraga, A. M., Ribeiro, R. J. T., & Medeiros, R. (2009) · Actas Urológicas Españolas · doi:10.1016/s0210-4806(09)72891-8 · Cited by 54
Lee, H., Lee, T., Lee, N., Yang, E. G., Lee, C., Lee, J., Moon, E., Ha, J., & Park, H. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr034 · Cited by 50
Hydroxylase-dependent regulation of the NF-κB pathway
Scholz, C. C., & Taylor, C. T. (2013) · Biological Chemistry · doi:10.1515/hsz-2012-0338 · Cited by 48
Zhang, M., Ma, Q., Hu, H., Zhang, D., Li, J., Ma, G., Bhat, K., & Wu, E. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.01.017 · Cited by 49
“Some studies showed that Akt over-expression could result in increased transcription or translation of HIF-1a, saturating VHL or other degradation machinery, and Akt could also impede the degradation of HIF-1a through inhibition of the VHL complex either directly or indirectly [22,40].”
Role of Carcinoma-Associated Fibroblasts and Hypoxia in Tumor Progression
Giaccia, A. J., & Schipani, E. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_73 · Cited by 48
Self-citationThompson, J. M., Nguyen, Q., Singh, M., Pavesic, M. W., Nesterenko, I., Nelson, L. J., Liao, A. C., & Razorenova, O. V. (2016) · Oncogene · doi:10.1038/onc.2016.272 · Cited by 46
Regulation of HIF by Prolyl hydroxylases: Recruitment of the Candidate Tumor Suppressor Protein ING4
Ozer, A., & Bruick, R. K. (2005) · Cell Cycle · doi:10.4161/cc.4.9.2040 · Cited by 46
Kalliri, E., Grzyska, P. K., & Hausinger, R. P. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.223 · Cited by 44
Hypoxia Inducible Factor Pathways as Targets for Functional Foods
Losso, J. N., & Bawadi, H. A. (2005) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0479719 · Cited by 43
Bock, K. D., Smet, F. D., de Oliveira, R. L., Anthonis, K., & Carmeliet, P. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0482-z · Cited by 43
“For instance, v-Src and Ras stabilize HIFs, presumably by blocking prolyl hydroxylation by PHDs, though the precise mechanisms remain to be defined [58].”
BackgroundProceedings of the Oxygen Homeostasis/Hypoxia Meeting
Kaufman, B., Scharf, O., Arbeit, J., Ashcroft, M., Brown, J. M., Bruick, R. K., Chapman, J. D., Evans, S. M., Giaccia, A. J., Harris, A. L., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2611 · Cited by 38
Self-citationChu, P. W. Y., Beart, P. M., & Jones, N. M. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.02.008 · Cited by 42
“Chavez et al. (2006) have reported that HIF-2 might be an importantmediator of the adaptive response of astrocytes to hypoxia or hypoxia-mimetic agents by increasing the levels of Epo.”
BackgroundBICD1 mediates HIF1α nuclear translocation in mesenchymal stem cells during hypoxia adaptation
Lee, H. J., Jung, Y. H., Oh, J. Y., Choi, G. E., Chae, C. W., Kim, J. S., Lim, J. R., Kim, S. Y., Lee, S., Seong, J. K., et al. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0241-1 · Cited by 42
Natural antisense transcripts of HIF-1α are conserved in rodents
Rossignol, F., de Laplanche, E., Mounier, R., Bonnefont, J., Cayre, A., Godinot, C., Simonnet, H., & Clottes, E. (2004) · Gene · doi:10.1016/j.gene.2004.06.029 · Cited by 42
When hypoxia signalling meets the ubiquitin-proteasomal pathway, new targets for cancer therapy
Brahimi‐Horn, C., & Pouysségur, J. (2004) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2004.09.003 · Cited by 41
Regulation of Bone Marrow Angiogenesis by Osteoblasts during Bone Development and Homeostasis
Schipani, E., Wu, C., Rankin, E. B., & Giaccia, A. J. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00085 · Cited by 40
Self-citationChen, Y., Shi, G., Xia, W., Kong, C. S., Zhao, S., Gaw, A. F., Chen, E. Y., Yang, G. P., Giaccia, A. J., Le, Q., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0899 · Cited by 40
Self-citationHIF–prolyl hydroxylases and cardiovascular diseases
Banerjee, S. S., Thirunavukkarasu, M., Rishi, M. T., Sánchez, J. A., Maulik, N., & Maulik, G. (2012) · Toxicology Mechanisms and Methods · doi:10.3109/15376516.2012.673088 · Cited by 39
“Stabilization of HIF-1α under normoxic conditions is mediated by inhibition of prolyl hydroxylation as found in RAS Val12 and v-Src activation (Chan et al. 2002).”
BackgroundKaynar, M. Y., Sanuş, G. Z., Hnimoglu, H., Kaçıra, T., Kemerdere, R., Atukeren, P., Gümüştaş, K., Canbaz, B., & Tanrıverdi, T. (2008) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2007.07.080 · Cited by 39
Participation of HIFs in the regulation of Sertoli cell lactate production
Galardo, M. N., Gorga, A., Merlo, J. P., Regueira, M., Pellizzari, E. H., Cigorraga, S. B., Riera, M. F., & Meroni, S. B. (2016) · Biochimie · doi:10.1016/j.biochi.2016.10.006 · Cited by 38
Hypoxia modulates the activity of a series of clinically approved tyrosine kinase inhibitors
Ahmadi, M., Ahmadihosseini, Z., Allison, S. J., Begum, S., Rockley, K. L., Sadiq, M., Chintamaneni, S., Lokwani, R., Hughes, N., & Phillips, R. M. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12438 · Cited by 37
“As cobalt chloride is known to stabilise HIF2α in aerobic conditions (Chan et al., 2002), our results (figure 6) also suggest that HIF2 is not involved in the hypoxic sensitisation of cells to dasatinib.”
Targeting the Loss of the von Hippel-Lindau Tumor Suppressor Gene in Renal Cell Carcinoma Cells
Sutphin, P. D., Chan, D. A., Li, J. M., Turcotte, S., Krieg, A. J., & Giaccia, A. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0604 · Cited by 36
“Hydroxylation of Pro(531) of HIF-2a is essential for VHL binding (7, 13).”
BackgroundSelf-citationMontero-Morán, G. M., Li, M., Rendon‐Huerta, E. P., Jourdan, F. L., Lowe, D. J., Stumpff‐Kane, A. W., Feig, M., Scazzocchio, C., & Hausinger, R. P. (2007) · Biochemistry · doi:10.1021/bi700065h · Cited by 36
Hirami, Y., Aoe, M., Tsukuda, K., Hara, F., Otani, Y., Koshimune, R., Hanabata, T., Nagahiro, I., Sano, Y., Date, H., et al. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.04.028 · Cited by 36
Dehne, N., Kerkweg, U., Otto, T., & Fandrey, J. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00892.2006 · Cited by 34
“DMOG (1 mM), a known inhibitor of the prolyl hydroxylase enzyme family (6), was added directly at the beginning of the experiment.”
BackgroundOxygen Sensing: A Common Crossroad in Cancer and Neurodegeneration
Quaegebeur, A., & Carmeliet, P. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_83 · Cited by 33
“Accordingly, PHD activity is reduced in several tumor cell lines (Calvisi et al. 2007; Chan et al. 2002; Kato et al. 2006; Knowles et al. 2003).”
BackgroundYoshikawa, Y., Takano, O., Kato, I., Takahashi, Y., Shima, F., & Kataoka, T. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.09.017 · Cited by 33
“[23] Chan DA, Sutphin PD, Denko NC, and Giaccia AJ.”
BackgroundWillam, C., Nicholls, L. G., Ratcliffe, P. J., Pugh, C. W., & Maxwell, P. H. (2004) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2003.11.017 · Cited by 33
Dual faces of angiogenesis: Mechanisms and therapeutic applications
Izadpanah, R., Izadpanah, A., & Alt, E. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189494 · Cited by 31
Targeting the Mevalonate Pathway Suppresses VHL-Deficient CC-RCC through an HIF-Dependent Mechanism
Thompson, J. M., Álvarez, A., Singha, M. K., Pavesic, M. W., Nguyen, Q., Nelson, L. J., Fruman, D. A., & Razorenova, O. V. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-1076 · Cited by 32
Src induces expression of carbonic anhydrase IX via hypoxia-inducible factor 1
Takáčová, M., Holotnakova, T., Baráthová, M., Pastoreková, S., Kopáček, J., & Pastorek, J. (2010) · Oncology Reports · doi:10.3892/or_00000709 · Cited by 32
Sable, C., Aliyu, Z. Y., Dham, N., Nouraie, M. S., Sachdev, V., Sidenko, S., Miasnikova, G., Polyakova, L. A., Sergueeva, A., Okhotin, D. J., et al. (2011) · Haematologica · doi:10.3324/haematol.2011.051839 · Cited by 32
“0002), serum erythropoietin (50 [21-132] vs.”
NADH elevation during chronic hypoxia leads to VHL-mediated HIF-1α degradation via SIRT1 inhibition
Joo, H.-Y., Jung, J. K., Kim, M., Woo, S. R., Jeong, J. M., Park, E., Kim, Y., Park, J., Kim, J., Yun, M., et al. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01130-3 · Cited by 28
“Under conditions of normoxia, degradation of HIF-1α occurs via hydroxylation by proline hydroxylase (PHD) and subsequent recruitment of von-Hippel Lindau (VHL) tumor suppressor with E3 ligase activity [16, 17].”
BackgroundGenome-independent hypoxic repression of estrogen receptor alpha in breast cancer cells
Padró, M., Louie, R. J., Lananna, B. V., Krieg, A. J., Timmerman, L., & Chan, D. A. (2017) · BMC Cancer · doi:10.1186/s12885-017-3140-9 · Cited by 28
Self-citationIron deficiency modifies gene expression variation induced by augmented hypoxia sensing
Zhang, X., Zhang, W., Ma, S., Miasniakova, G., Sergueeva, A., Ammosova, T., Xu, M., Nekhai, S. A., Nourai, M., Wade, M. S., et al. (2013) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2013.07.016 · Cited by 28
“Hypoxia has diverse effects on gene expression as investigated in cells in vitro [8], and lack of iron can further enhance pathways that are associated with hypoxia [10; 11].”
Cutroneo, K. R., White, S. L., Chiu, J., & Ehrlich, H. P. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20750 · Cited by 28
“Prolyl hydroxylation is inhibited by hypoxia and ferrous iron chelators such as desferrioxamine [Chan et al., 2002].”
BackgroundHypoxia‐inducible factors – regulation, role and comparative aspects in tumourigenesis
Hansen, A. E., Kristensen, A. T., Law, I. G., Jørgensen, J. T., & Engelholm, S. A. (2010) · Veterinary and Comparative Oncology · doi:10.1111/j.1476-5829.2010.00233.x · Cited by 28
HIF gene expression in cancer therapy
Chan, D. A., Krieg, A. J., Turcotte, S., & Giaccia, A. J. (2007) · Methods in Enzymology · doi:10.1016/s0076-6879(07)35016-7 · Cited by 26
Self-citationFábián, Z., Ramadurai, S., Shaw, G., Nasheuer, H., Kölch, W., Taylor, C. T., & Barry, F. (2014) · Stem Cell Research · doi:10.1016/j.scr.2014.02.007 · Cited by 25
“PHD-mediated prolyl hydroxylation of the alpha subunit, however, induces its ubiquitination and proteasomal degradation preventing the formation of the active HIF-1α/β heterodimers (Chan et al., 2002; Ivan et al., 2002; Masson et al., 2001).”
BackgroundNolan, K. A., Brennan, E. P., Scholz, C. C., Cullen, C., Ryan, A., Taylor, C. T., & Godson, C. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.07.034 · Cited by 23
Paradziej-Łukowicz, J., Skwarska, A., Peszyńska-Sularz, G., Brillowska‐Dąbrowska, A., & Konopa, J. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.12.7.15980 · Cited by 23
Isaja, L., Mucci, S., Vera, J., Rodríguez-Varela, M. S., Marazita, M. C., Morris-Hanon, O., Videla-Richardson, G. A., Sevlever, G. E., Scassa, M. É., & Romorini, L. (2020) · Scientific Reports · doi:10.1038/s41598-020-77792-7 · Cited by 22
Classical Angiogenic Signaling Pathways and Novel Anti-Angiogenic Strategies for Colorectal Cancer
Cao, M., Wang, Y., Lu, G., Qi, H., Li, P., Dai, X., & Lü, J. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44100305 · Cited by 23
“In addition, SRC could stabilize the content of HIF-1α under normoxic conditions by inhibiting prolyl hydroxylation [28].”
BackgroundWu, S. K., Ariffin, J. K., Tay, S. C., & Picone, R. (2023) · Aging Cell · doi:10.1111/acel.13766 · Cited by 22
“HIF- 1α is also known to be activated by Ras signalling (Chan et al., 2002).”
BackgroundZhang, T., Xie, J., Sun, K., Fu, N., Deng, S., Lin, S., Shi, S., Zhong, J., & Lin, Y. (2016) · Cell Proliferation · doi:10.1111/cpr.12239 · Cited by 22
The expression of hypoxia-inducible factor-1 in primary brain tumors
Reszeć, J., Rutkowski, R., & Chyczewski, L. (2013) · International Journal of Neuroscience · doi:10.3109/00207454.2013.789874 · Cited by 22
“[8] examined HIF-1 and Bax protein expression in glioblastoma cells, concluding that Bax expression did render glioblastoma cells more sensitive to radiation under hypoxic conditions.”
BackgroundLiu, L., & Clipstone, N. A. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21801 · Cited by 22
“…it has become increasingly apparent that there are additional signaling pathways and mechanisms that allow for the activation of HIF-1 under normal oxygen conditions [Laughner et al., 2001; Lukashev et al., 2001; Chan et al., 2002; Page et al., 2002; Jung et al., 2003; Hirota et al., 2004].”
BackgroundFeng, Y., Zhu, H. Y., Ling, T., Bo, H., Zhang, G., & Shi, R. (2010) · Cell Biology International · doi:10.1042/cbi20090419 · Cited by 21
“Discussion HIF-1α is induced by hypoxia, and under non-hypoxic conditions HIF-1α is minimally expressed because of hydroxylation by a prolyl hydroxylase enzyme(Chan et al., 2002; To and Huang, 2005).”
BackgroundYan, H., Peng, Z.-G., Wu, Y., Jiang, Y., Yu, Y., Huang, Y., Zhu, Y., Zhao, Q., & Chen, G. (2005) · PubMed · Cited by 21
Zhu, H. Y., Feng, Y., Zhang, J., Zhou, X. J., Bo, H., Zhang, G., & Shi, R. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.11.11.15707 · Cited by 20
Illingworth, C. J. R., Loenarz, C., Schofield, C. J., & Domene, C. (2010) · Biochemistry · doi:10.1021/bi100358t · Cited by 20
Nimker, C., Kaur, G., Revo, A., Chaudhary, P., & Bansal, A. (2014) · The Journal of Physiological Sciences · doi:10.1007/s12576-014-0348-1 · Cited by 19
“Studies have reported the induction of HIF1 expression by PHD inhibitors and their role in tolerance to oxidative injury in primary astrocytes [5, 6, 37].”
IL‐4 enhances hypoxia induced HIF‐1α protein levels in human transformed intestinal cells
Scharte, M., Jurk, K., Kehrel, B. E., Zarbock, A., Aken, H. V., & Singbartl, K. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.10.053 · Cited by 18
Mucci, S., Isaja, L., Rodríguez-Varela, M. S., Ferriol-Laffouillere, S. L., Marazita, M. C., Videla-Richardson, G. A., Sevlever, G. E., Scassa, M. É., & Romorini, L. (2022) · Scientific Reports · doi:10.1038/s41598-022-23650-7 · Cited by 17
Dead Cells Don’t Form Tumors: HIF-Dependent Cytotoxins
Sutphin, P. D., Chan, D. A., & Giaccia, A. J. (2004) · Cell Cycle · doi:10.4161/cc.3.2.617 · Cited by 17
Self-citationMolecular Imaging of RNA Interference Therapy Targeting PHD2 for Treatment of Myocardial Ischemia
Huang, M., & Wu, J. C. (2010) · Methods in molecular biology · doi:10.1007/978-1-61737-982-6_13 · Cited by 15
“This is due to hydroxylation of two prolyl residues (Pro402 and Pro564) by a family of prolyl-4hydroxylases (PHDs) (12).”
Background
Metadata
- Authors
- Chan, D. A., Sutphin, P. D., Denko, N. C., & Giaccia, A. J.
- Affiliations
- Stanford University (US)
- Corresponding author
- Giaccia, Amato J.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-10
- Volume
- 277
- Issue
- 42
- Pages
- 40112-40117
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2044030331
- Cited by
- 264
- References
- 25
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 4 · 2023: 4 · 2022: 4 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 6 · 2017: 4 · 2016: 8 · 2015: 9 · 2014: 9 · 2013: 16 · 2012: 9
- FWCI
- 11.78
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6590 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (CA67166)
- National Cancer Institute (P01CA067166, CA09302, CA 67166, T32CA009302)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Kruppel-like factors research
- Keywords
- prolyl hydroxylation, hypoxia-inducible factor-1α, HIF-2α, HIF-1α stabilization, VHL, E3 ubiquitin ligase, post-translational modification, normoxia, oncogenic Ras, v-Src, deferoxamine, cobalt chloride
- MeSH terms
- Amino Acids, Dicarboxylic, Animals, Hypoxia, Chelating Agents, Cobalt, Deferoxamine, Fibroblasts, Hydroxylation, Iron, Luciferases, Proline, Protein Binding, Transcription Factors, Transfection, Immunoblotting, Mice, Knockout, Mice, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.